Ferroptosis, an iron-dependent form of regulated cell death (RCD), has been proven to affect the response to antineoplastic therapies.
However, little is known about the role of ferroptosis in chemotherapy and immune checkpoint inhibitor (ICI) therapy responses, as well as the molecular subtype identification of triple-negative breast cancer (TNBC).
